October 2006 Edit List

Article

October 2006 Edit List

Features

REFRACTIVE

Phakic IOLs: the right fit?
David R. Hardten, MD

Phakic IOLs: when things go wrong
Michael C. Knorz, MD

The battle of the giants: Tecnis versus ReSTOR
Beatrice Cochener, MD

Exchanging lenses for clear vision
Magda Rau, MD

Hyperopic presbyopia: a new term for an old problem and its modern solution
Zissis Bisogiannis, MD

RETINA

Avastin: all it's cracked up to be?
Fedra Pavlou

Vitrectomy for ocular diabetic complications: a terminal event?
Paul Tesha & Somnath Banerjee

PAEDIATRIC

Silicone hydrogel contact lenses: a viable option for children?
Jolanta Bendoriene, MD

GLAUCOMA

One site or two? The big question for combined cataract and glaucoma surgeries
Z. Mandic, J. Korcic, K. Novak-Laus, M. Zoric-Geber, G. Bencic

ECP: consider it earlier!
Phillip Bloom, MD

Phaco therapy for glaucoma patients?
M.M. Pravosudova & L.I. Balashevich

Regulars

In Focus

Eye on Industry

Society Spotlight

Product Watch

Letters

Events Calendar

*Subject to the Editor's discretion

Recent Videos
Thomas Aaberg, MD, gives an update on Neurotech Pharmaceuticals NT-501 device for the potential treatment of retinitis pigmentosa and age-related macular degeneration, including a projected PDUFA date from the FDA at the annual ASRS meeting in Stockholm, Sweden.
Sruthi Arepalli, MD, spoke with Modern Retina about her presentation, "Assessing retinal vascular changes in alzheimer disease with radiomics: A preliminary study of fundus photography" at the annual ASRS meeting in Stockholm, Sweden.
Nathan Steinle, MD, spoke with Modern Retina about the ongoing research on the durability of sozinibercept in combination therapy with anti-VEGF-A treatments at the annual ASRS meeting in Stockholm, Sweden.
Deepak Sambhara, MD, shared an overview of his paper-on-demand, which covered real-world safety and efficacy of aflibercept, 8 mg in the treatment of neovascular age-related macular degeneration at the annual ASRS meeting in Stockholm, Sweden.
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
© 2024 MJH Life Sciences

All rights reserved.